Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...
This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...
PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
and the pricing challenges from the GEM-X transition are expected to ease by the fourth quarter. William Blair keeps the ...
Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...
CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...
S&P 500 E-Mini futures are trending down -1.08% this morning as investors digest key U.S. inflation data and also await further testimony from Federal Reserve Chair Jerome P ...
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...
Hundreds of vendors from dozens of countries converged in Tucson, Arizona, for the annual Gem and Mineral Show, where the best and most impressive gems, minerals, and fossils turn the past into profit ...
20:21 EST Cathie Wood’s ARK Investment buys 250K shares of 10x Genomics (TXG) today Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results